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ABSTRACT
Six new CuL1 (L1 = 4-bromo-2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)phenol), CoL1, NiL1, CuL2 (L2 = 2-(1H-imidazo[4,5-f]
[1,10]phenanthroline-2-yl)-5-methoxyphenol), CoL2 and NiL2 complexes were synthesized. L1 and L2 ligands were prepared by
the condensation of 1,10-phenanthroline-5,6-dione with 5-bromosalicylaldehyde and 2-hydroxy-4-methoxybenzaldehyde,
respectively. The structures of the compounds were determined by elemental analyses, IR, UV-visible, 1H-NMR, TGA, magnetic
susceptibilities and molar conductance measurements. It is observed that the synthesized complexes have tetragonal and
distorted square pyramidal geometrical structures. Antibacterial activity of the ligands and their metal complexes were tested
against selected bacteria by disc diffusion method.
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1. Introduction
1,10-Phenanthroline (phen) and its derivations play important
roles for supramolecular assemblies because they can also provide
bidentate N-donor sites for chelating with metal ions to form
bridge ligands.1–4 Derivatives of phen are very important ligands
in organometallic chemistry;5,6 some of their complexes, for
example, bind to DNA.7–10
Metal complexes of the type [M(LL)3]
n+ where LL is either phen
or a modified phen ligand, are particularly attractive species to
recognize and cleave DNA.11–13 Systematic studies of substituted
derivatives of phen have been successfully undertaken.14
1,10-phenanthroline, as well as some of its derived complexes,
do exhibit antimicrobial properties.15,16 The photocemical and
redox properties of complexes can be varied systematically
through appropriate substition on the phenanthroline rings.17,18
Firstly, we synthesized and characterized Cu(II), Co(II) and
Ni(II) complexes with phen imidazole derivatives, which are
4-bromo-2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)phenol
(L1) and 2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)-5-
methoxyphenol (L2) (Fig. 1). Secondly, these compounds were
screened for antibacterial activity against such bacterial strains
as A. hydrophila, S. aureus, K. pneumoniae, P. aeruginosa, S. marces-
cens, E. aerogenes, B. subtilis, E. coli and E. faecalis.
2. Experimental
2.1. Materials and Physical Measurements
1,10-phenanthroline-5,6-dione was synthesized according to a
published method.19 Ethanol was dried over anhydrous copper
(II) sulfate and distilled over metallic sodium. All other chemicals
were of analytical grade and were used as purchased.
Elemental analyses (C, H, N) were performed by using a
Leco 932 elemental analyzer. 1H NMR spectra were recorded on
a Bruker 300 MHz spectrometer in DMSO-d6. The IR spectra
were obtained using KBr discs on an Ati Unicam Mattson
1000 Series FT-IR spectrophotometer. The electronic absorption
spectra in the 200–1100 nm range were obtained in DMF on a
Shimadzu UV-1700 UV-Visible spectrophotometer. Magnetic
susceptibility measurements were carried out by the Gouy
method at room temperature using Hg[Co(SCN)4] as a reference
for calibrant. Conductivities of a 10–3 M solution of the complexes
were measured in DMF at 25 °C using a CMD 750 WPA model
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Figure 1 Structure of the (a) L1 and (b) L2 ligands.
* To whom correspondence should be addressed. E-mail: mesutgomleksiz@gmail.com
conductivity meter. Thermogravimetric analyses (TGA) were
carried out by Shimadzu-50 thermal analyzer in a dynamic
nitrogen atmosphere in the 20–600 °C range and a heating rate
of 20 °C min–1.
2.2. Antibacterial Activity
The in vitro antibacterial screening effects of the ligands (L1, L2)
and their metal complexes were tested against nine bacterial
strains, namely A. hydrophila ATCC 7966, S. aureus ATCC 29213,
K. pneumoniae ATCC 21541, P. aeruginosa ATCC 27853, S. marces-
cens ATCC 21074, E. aerogenes ATCC 5402, B. subtilis ATCC 6633, E.
coli ATCC 25922 and E. faecalis ATCC 29212 by disc diffusion
method using nutrient agar medium for antibacterial activity.20
All bacteria were inoculated into Nutrient Broth (Difco) and
incubated for 24 h. In the agar well diffusion method (Mueller
Hinton Agar (Oxoid) for bacteria), the dilution plate method was
used to enumerate microorganisms (105 bacteria per mL) for
24 h.21 Using a sterilized cork borer (6 mm diameter), wells were
dug in the culture plates. Metal complexes and ligands were per-
formed at the fixed concentration of 2000 µg mL–1 and com-
pounds dissolved in DMF. Compounds dissolved in DMF were
added (75 µL) to these wells. The petri dishes were left at 4 °C for
2 h and then the plates were incubated at 37 °C and 30 °C for bac-
teria (18–24 h). At the end of the period, inhibition zones formed
on the medium were evaluated is milimetres. DMF was used as
negative control under similar conditions for comparison.
Ampicillin (AMP) was used as the reference drug in positive con-
trols. The experiments were performed in triplicate.
2.3. Statistical Analysis
In this study, repeated measures analysis of variance was used
to evaluate the data. Ligands and their metal complexes were
analyzed antibacterial activity at different temperatures. Statisti-
cal significance was determined using Duncan multiple compar-
ison test and Bonferroni multiple comparison test was used for
grouping within subject factors. SPSS 15.0, version 8, software
was used in the statistical analyses.22
2.4. Synthesis of Ligands (L1, L2)
Ligands (L1, L
2) were synthesized by a method similar to one
described previously.18
4-bromo-2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)phenol (L1)
A mixture of 1,10-phenanthroline-5,6-dione (0.2 g, 1 mmol),
ammonium acetate (1.54 g, 20 mmol), 5-bromosalicylaldehyde
(0.22 g, 1.1 mmol) and glacial acetic acid (25 mL) was refluxed for
2 h, then cooled to room temperature and diluted with water
(50 mL). Dropwise addition of concentrated aqueaus ammonia
to neutralize gave a yellow precipitate, which was collected and
washed with water. The crude product dissolved in ethanol was
purified by filtration on silica gel. The principal yellow band was
collected. Evaporation of the solution gave yellow crystals. It
was filtered, washed with ethanol and recrystallized from ethanol
then dried at 80 °C. Yield: 0.311 g (79 %). IR (å, cm–1): 3245–2420
(N–H and O–H...N), 1607 (C=N imidazole ring), 1574, 1563,
1539, 1503 (C=C aromatic and C=N phenanthroline ring); ÇH
(300 MHz, DMSO-d6): 13.6 (1H, s, OH), 12.82 (1H, s, NH),
8.97–8.91 (2H, d, CAr – H), 8.63–8.56 (2H, dd, CAr – H), 8.18–8.13
(1H, d, CAr – H), 7.71–7.61 (2H, dd, CAr – H), 7.46–7.39 (1H, dd, CAr –
H) and 6.98–6.92 ppm (1H, d, CAr – H); UV-Vis (in DMF, nm):
277, 286, 303, 324, 337, 357, 407 and 552.
2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)-5-methoxyphenol (L2)
L2 was synthesized by a procedure similar to that for L1 except
that 2-hydroxy-4-methoxybenzaldehyde was used, and was
obtained as yellow powder. Yield: 0.147 g (43 %). IR (å, cm–1):
3274–2456 (N–H and O–H...N), 1604 (C=N imidazole ring), 1591,
1563, 1544, 1508 (C=C aromatic and C=N phenanthroline ring),
1256 (Ar-O-CH3); ÇH (300 MHz, DMSO-d6): 15.81 (1H, s, OH),
12.85 (1H, s, NH), 9.06–8.81 (4H, m, CAr – H), 7.86–7.71 (3H, m,
CAr – H), 7.11–6.97 (2H, m, CAr – H) and 3.86 (3H, s, OCH3); UV-Vis
(in DMF, nm): 279, 340, 356, 413, 445 and 550.
2.5. Synthesis of Complexes
CuL1, CoL
1 and NiL1
A solution of a metal salt (0.1 mmol) in DMF (2 mL) was added
to a hot solution of the L1 (0.078 g, 0.2 mmol) in DMF (10 mL). The
reaction mixture was heated at 80 °C until the reaction was
complete. The mixture was then left for two weeks at room
temperature, filtered, washed with DMF, water and ethanol and
dried at 100 °C in a vacuum oven. The following salts were used
for the synthesis; CuCl2.H2O (0.017 g, 10 h reaction time),
CoCl2.6H2O (0.030 g, 24 h reaction time), NiCl2.6H2O (0.020 g,
10 h reaction time).
CuL1: Green compound. Yield: 0.048 g (52 %). IR (å, cm–1):
3208–2540 (N–H and O–H...N), 1604 (C=N imidazole ring), 1580,
1541, 1511 (C=C aromatic and C=N phenanthroline ring);
UV-Vis (in DMF, nm): 453 and 700; (Found: C, 48.96; H, 2.54;
N, 11.97 %. Calc. for C38H22N8O2Cl2Br2Cu (916.89); C, 49.78;
H, 2.42; N, 12.22 %); µeff: 1.86 BM; iM (10
–3 M, in DMF, t–1 cm2
mol–1): 12.43.
CoL1: Brown compound. Yield: 0.049 g (53 %). IR (å, cm–1): 3428
(O–H, H2O), 3190–2406 (N–H and O–H...N), 1607 (C=N
imidazole ring), 1583, 1541, 1511 (C=C aromatic and C=N
phenanthroline ring); UV-Vis (in DMF, nm): 502; (Found: C,
50.21; H, 3.11; N, 11.50 %. Calc. for C38H24N8O3Cl2Br2Co (930.30);
C, 49.06; H, 2.60; N, 12.04 %); µeff: 4.83 BM; iM (10
–3 M, in DMF,
t
–1 cm2 mol–1): 76.84.
NiL1: Orange compound. Yield: 0.066 g (63 %). IR (å, cm–1):
3126-2460 (N–H and O–H...N), 1604 (C=N imidazole ring), 1583,
1541, 1511 (C=C aromatic and C=N phenanthroline ring);
UV-Vis (in DMF, nm): 452; (Found: C, 43.87; H, 2.88; N, 10.58 %.
Calc. for C38H22N8O2Cl4Br2Ni2 (1041.64); C, 43.82; H, 2.13; N,
10.76 %); µeff: 1.53 BM; iM (10
–3 M, in DMF, t–1 cm2 mol–1): 10.34.
CuL2: A ethanolic (20 mL) solution of the (0.025 g, 0.15 mmol)
CuCl2.H2O was added to a hot ethanolic (40 mL) solution of the
L2 (0.100 g, 0.3 mmol). The mixture was refluxed for 24 h. The
mixture was cooled to room temperature, the resulting green
solid was filtered, washed with DMF and ethanol then dried at
100 °C in a vacuum oven. Yield: 0.082 g (67 %). IR (å, cm–1):
3215–2405 (N–H and O–H...N), 1604 (C=N imidazole ring), 1591,
1577, 1544, 1508 (C=C aromatic and C=N phenanthroline ring),
1248 (Ar-O-CH3); UV-Vis (in DMF, nm): 470; (Found: C, 59.20;
H, 4.06; N, 12.93 %. Calc. for C40H28N8O4Cl2Cu (819.15); C, 58.65;
H, 3.45; N, 13.68 %); µeff: 2.13 BM; iM (10
–3 M, in DMF, t–1 cm2
mol–1): 14.82.
CoL2 and NiL2
A solution of a metal salt (0.15 mmol) in DMF (2 mL) was added
to a hot solution of the L2 (0.100 g, 0.3 mmol) in DMF (10 mL). The
mixture was heated at 80 °C while stirring for 24 h. The mixture
was left for two weeks at room temperature, the resulting solid
was filtered, washed with DMF, water and ethanol then dried at
100 °C in a vacuum oven. The following salts were used for the
synthesis; CoCl2.6H2O (0.038 g), NiCl2.6H2O (0.036 g).
CoL2: Brown compound. Yield: 0.057 g (46 %). IR (å, cm–1): 3423
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(O–H, H2O), 3115–2400 (N–H and O–H...N), 1604 (C=N
imidazole ring), 1591, 1577, 1544, 1508 (C=C aromatic and C=N
phenanthroline ring), 1248 (Ar-O-CH3); UV-Vis (in DMF, nm):
487, 606, 926; (Found: C, 58.56; H, 4.06; N, 13.15 %. Calc. for
C40H30N8O5Cl2Co (832.56); C, 57.71; H, 3.63; N, 13.46 %); µeff:
4.92 BM; iM (10
–3 M, in DMF, t–1 cm2 mol–1): 17.65.
NiL2: Orange compound. Yield: 0.052 g (40 %). IR (å, cm–1): 3410
(O–H, H2O), 3115–2280 (N–H and O–H...N), 1604 (C=N
imidazole ring), 1591, 1577, 1544, 1508 (C=C aromatic and C=N
phenanthroline ring), 1248 (Ar-O-CH3); UV-Vis (in DMF, nm):
500, 595, 902; (Found: C, 55.16; H, 3.98; N, 11.63 %. Calc. for
C40H34N8O7CI2Ni (868.35); C, 55.33; H, 3.95; N, 12.90 %); µeff:
3.26 BM; iM (10
–3 M, in DMF, t–1 cm2 mol–1): 148.42.
3. Results and Discussion
Elemental analyses indicate that the metal:ligand ratio is 1:1 in
the case of the NiL1 complex and 1:2 in the case of the other
complexes. In addition, the magnetic moment value of NiL1
complex indicates a dimeric structure (Figs. 2, 3). The ligands L1
and L2 were soluble in EtOH, DMF and DMSO, and the com-
plexes in DMF and DMSO. The melting points of the all com-
pounds were not observed due to decomposition.
3.1. IR Spectra
In IR spectra of CoL1, CoL2 and NiL2, the bands are observed at
the 3428, 3423 and 3410 cm–1 as broad bands are due to the OH
stretching vibrations of H2O molecules.
23,24,25
The broadened band between 3274–2420 cm–1 in IR spectra
of the L1 and L2 ligands is due to the stretching vibrations of the
both NH of the imidazole ring and intramolecular hydrogen
bonding (O–H...N) formed between phenolic OH and nitrogen
atom of C=N group of imidazole ring.26 The same band was
observed in IR spectra of metal complexes of these ligands. This
observation confirmed that phenolic OH and nitrogen (C=N) of
the imidazole ring do not participate in coordination. Moreover,
the stretching vibration of the C=N group (imidazole ring) of
the ligands L1 and L2 were not significantly affected in their com-
plexes, indicating that the nitrogen atom of this group is not in-
volved in coordination for all the complexes. On the other hand,
the bands of the C=N (phenanthroline ring) and C=C (Aro-
matic) groups were shifted to higher frequencies in all the com-
plexes of L1 and the band at 1563 cm–1 in the free L2 ligand was
shifted to higher frequencies (1577 cm–1) in their complexes,27,28
that indicates the participation of the C=N (phenanthroline
ring) groups in coordination of the metal ion.
The bands of the N-H and O–H...N groups in all the complexes
of L1 shifted to negative frequencies after complexations. The
N-H, O–H...N and Ar-O-CH3 groups in all complexes of L
2 are
the some as complexes of L1. The negative frequency shifts of
these groups may be attributed to flow of electrons from these
groups to the phenanthroline ring due to electron flow from the
nitrogen atom of the phenanthroline ring to the metal ion after
complexations.
3.2. Electronic Spectra and Magnetic Measurements
In the electronic spectra of L1 and L2 ligands, the bands are
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Figure 2 Structure of the CuL1, CoL1 and NiL1 complexes.
Figure 3 Structure of the CuL2, CoL2 and NiL2 complexes.
observed in the range of 277–552 nm and 279–550 nm, respec-
tively. These bands are attributed to é Ã é* and n Ã é* transi-
tions.29,30
The magnetic moment values for the Cu(II) complexes lies in
the range 1.86–2.13 BM corressponding to one unpaired electron.31
The complexes may be considered to possess a tetragonal geom-
etry. The electronic spectra of CuL1 complex shows two bands





sitions, respectively. The band observed at 470 nm for CuL2






band assigned to 2B1g Ã
2A1g transition cannot be detected for the
CuL2 complex.32
The magnetic moment values for the Co(II) complexes in the
range 4.83–4.92 BM reported here show that there are three
unpaired electrons, indicating a high spin octahedral configura-
tion.31 The electronic spectra of CoL2 complex give three bands

















4Eg), respectively. The band observed at 502 nm for the CoL
1
complex is assigned to 4Eg Ã T1g(P)(
4Eg). The positions of these
bands suggest a tetragonal environment around Co2+ ion.32 The
other bands of CoL1 are not observed because they might be
overlap with bands of the L1 ligand.
The low µeff (1.53 BM) of NiL
1 complex indicate a dimeric struc-
ture.31,33 The band observed at 452 nm for NiL1 complex is
assigned to 3B1 Ã
3A2,
3E(P) of a distorded square pyramidal struc-
ture. The other band assigned to 3B1 Ã
3B2is not observed because
it overlaps with ligand bands of L1. The magnetic moment value
(3.26 BM) for NiL2 corresponds to two unpaired electron.31 The
electronic spectrum of this complex shows absorption bands at














3Eg) transitions, respectively, in a tetragonal
geometry around the Ni2+ ion.32
3.3. Thermal Analysis (TGA)
According to the thermogravimetric results CuL1, NiL1, and
CuL2 exhibited rather high thermal stability with decomposition
temperatures of 320, 280 and 270 °C, respectively. CoL1, CoL2 and
NiL2 complexes were stable up to 175, 50 and 50 °C, respectively.
In the decomposition process of these complexes, the mass loss
corresponded to one coordinated water molecule in the temper-
ature range 175–240 °C for CoL1 (2.08 % experimental; 1.93 %
calculated), one uncoordinated water molecule in the tempera-
ture range 50–100 °C for CoL2 (2.50 % experimental; 2.60 % calcu-
lated) and NiL2 (2.08 % experimental; 2.10 % calculated). In the
second stage of the decomposition process of NiL2 the mass loss
corresponded to two coordinated water molecules in the temper-
ature range 160–250 °C (4.16 % experimental; 4.14 % calculated).
3.4. Conductance Measurements
Conductivity measurements of CoL1 complex resulted in iM
76.84 t–1cm2 mol–1, which indicates that it is of the 1:1 electrolyte
type. NiL2 had an iM value of 148.42 t
–1 cm2 mol–1) indicating
that it is of the 2:1 electrolyte type. The other complexes were
nonelectrolytes.34
3.5. Antibacterial Activity
Test results of antibacterial screening are summarized in Tables
1 and 2. According to the results of the antibacterial activity,
ligands and all their metal complexes showed antibacterial activity
at 30 °C and 37 °C in which there is no distinction between
antibacterial activity. The Duncan’s multiple range test indicated
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significant differences of antibacterial activity among ligands
and their metal complexes. The ligands displayed weak antibac-
terial activity against B. subtilis. However, good activity was ob-
served against others bacteria. Cu(II) complexes displayed good
antibacterial activity against all bacteria except for B. subtilis.
Co(II) complexes exhibited activity against S. aureus, B. subtilis,
A. hydrophila, K. pneumoniae, E. aerogenes and E. coli. However, no
activity was observed against S. marcescens, E. coli and P. aerugi-
nosa. Additionally, Ni(II) complexes exhibited weak effect
against to all bacteria tested.
Finally, these results may suggest that the ligands and their
metal complexes can be used as antibacterial agents in new
drugs for therapy of infectious diseases in humans.
4. Conclusion
In this study, imidazole and phenanthroline containing
4-bromo-2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)phenol
(L1), 2-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)-5-metho-
xyphenol) (L2) and their complexes were synthesized and char-
acterized. The analytical data and spectroscopic studies suggest
that the complexes were of the general formula: [M(L1)2XY]CIn
where M is Cu(II) (X = CI, Y = CI, n = 0), Co(II) ( X = CI, Y = H2O,
n = 1), [M2(L
1)2CI4] where M = Ni(II) and [M(L
2)2X2]CInmH2O
where M is Cu(II) (X = CI, n = 0, m=0), Co(II) (X = CI, n = 0,
m=1) and Ni(II) (X = H2O, n = 2, m=1). According to the IR data
of the compounds, ligands (L1, L2) are coordinated to the metal
ions through nitrogen atoms of the C=N (phenanthroline ring)
groups.
The results obtained from this research demonstrated that all
synthesized compounds have antibacterial activity against
the bacterial strains. In this sense, we think that the ligands and
their metal complexes might be effective as antibacterial agents
against bacteria.
Acknowledgements
We are grateful to Firat University Research Foundation for the
support of this research.
References
1 S. Bodige and F.M. MacDonnell, Tetrahedron Lett., 1997, 38, 8159–8160.
2 W. Paw and R. Eisenberg, Inorg. Chem., 1997, 36, 2287–2293.
3 K. Nobuko, K. Ryuzi, H. Yuichiro, S. Hideki, A. Hironori, and K.
Kazuyuki, J. Chem. Soc., Dalton Trans., 2000, 18, 3053–3054.
4 V. Balzani, A. Juris, M. Venturi, S. Campagna and S. Serroni, Chem.
Rev., 1996, 96, 759–833.
5 E.C. Constable, Metals and Ligands Reactivity, VCH, Weinheim, 1996,
p. 308.
6 J.P. Sauvage, J.P. Collin, J.C. Chambron, S. Guillerez, C. Coudret,
V. Balzani, F. Barigeletti, L. De Cola and L. Flamingi, Chem. Rev., 1994,
94, 993–1019.
7 R.E. Holmlin, P.J. Dandliker and J.K. Barton, Angew. Chem., 1997, 36,
2714–2730.
8 F. Gao, H. Chao, J.Q. Wang, Y.X. Yuan, B. Sun, Y.F. Wei, B. Peng and
L.N. Ji, J. Biol. Inorg. Chem., 2007, 12, 1015–1027.
9 Q.L. Zhang, J.H. Liu, J.Z. Liu, P.X. Zhang, X.Z. Ren, Y. Liu, Y. Huang
and L.N. Ji, J. Inorg. Biochem., 2004, 98, 1405–12.
10 X.W. Liu, L.C. Xu and H. Li, H. Chao, K.C. Zheng and L.N. Ji, J. Mol.
Struct., 2009, 920, 163–171.
11 D.S. Sigman, Acc. Chem. Res., 1986, 19, 180–186.
12 Y. Jenkins, A.E. Friedman, N.J. Turro and J.K. Barton, Biochemistry,
1992, 31, 10809–10816.
13 D.L. Carlson, D.H. Huchital, E.J. Mantilla, R.D. Sheardy and W.R.
Murphy, J. Am. Chem. Soc., 1993, 115, 6424–6425.
14 A. Masood and D.J. Hodgson, Inorg. Chem., 1993, 32, 4839–4844.
15 B. Coyle, K. Kwanagh, M. McCann, M. Devereux and M. Geraghty,
Biometals., 2003, 16, 321–329.
RESEARCH ARTICLE M. Gomleksiz, C. Alkan and B. Erdem, 111





























































































































































































































































































































































































































































































































































































































































































































































16 H. Qizhuang, Y. Jing, M. Hui and L. Hexing, Materials Letters, 2006, 60,
317–320.
17 J. Bolger, A. Gourdon, E. Ishow and J. P. Launay, Inorg. Chem., 1996, 35,
2937–2944.
18 H. Xu, K.C. Zheng, Y. Chen, Y.Z. Li, L.J. Lin, H. Li, P.X. Zhang and L.N.
Ji, Dalton Trans., 2003, 11, 2260–2268.
19 C. Hiort, P. Lincoln and B. Norden, J. Am. Chem. Soc., 1993, 115,
3448–3454.
20 D. Greenwood, R. Snack and J. Peurtherer, Medical Microbiology: A
Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Diagno-
sis and Control, 15th edn., Churchill Livingstone, Edinburgh, United
Kingdom, 1997, p. 690.
21 V. Reddy, N. Patil and S.D. Angadi, E. J. Chem., 2008, 5, 577–583.
22 SAS User’s Guide: Statistics, Ver. 8, SAS 2001, SAS Institute, Cary,
NC.mm
23 H. Adams, R. Bastida, A. De Blas, M. Carnota, D.E. Fenton, A. Maci’as,
A. Rodriguez and T. Rodriguez-Blas, Polyhedron, 1997, 16, 567–572.
24 W. Radecka-Paryzek and V. Patroniak, Polyhedron, 1994, 13, 2125–
2128.
25 S. Liu, L.W. Yang, S.J. Rettig and C. Orvig, Inorg. Chem., 1993, 32,
2773–2778.
26 J.G. Liu, B.H. Ye, H. Li, Q.X. Zhen, L.N. Ji and Y.H. Fu, J. Inorg.
Biochem., 1999, 76, 265–271.
27 D.H. Busch and J.C. Bailar Jr, J. Am. Chem. Soc., 1956, 78, 1137–1142.
28 M.M. Mashaly, H.F. El-Shafiy, S.B. El-Maraghy and H.A. Habib,
Spectrochim. Acta A., 2005, 61, 1853–1869.
29 J. Bolger, A. Gourdon, E. Ishow and J.P. Launay, J. Chem. Soc., Chem.
Commun., 1995, 17, 1799–1800.
30 J. Bolger, A. Gourdon, E. Ishow and J.P. Launay, Inorg. Chem., 1996, 35,
2937–2944.
31 J.E. Huheey, E.A. Keiter and R.L. Keiter, Inorganic Chemistry, Principle
of Structure and Reactivity, Harper Collins College Publisher, New
York, 1993, p. 1052.
32 A.B.P. Lever, Inorganic Electronic Spectroscopy, Elsevier, Amsterdam,
1986, p. 863.
33 F.A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry,
Wiley-Interscience Publication, New York, 1980, p. 1396.
34 W.J. Geary, Coord. Chem. Rev., 1971, 7, 81–122.
RESEARCH ARTICLE M. Gomleksiz, C. Alkan and B. Erdem, 112
S. Afr. J. Chem., 2013, 66, 107–112,
<http://journals.sabinet.co.za/sajchem/>.
